The University of Chicago Header Logo

Connection

Ravi Salgia to Central Nervous System

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Central Nervous System.
Ravi Salgia
Connection Strength
0.024
Central Nervous System
  1. A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. Br J Cancer. 2012 Feb 28; 106(5):839-45.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.